A synthetic retinoic acid receptor γ antagonist (7C)-loaded nanoparticle enhances bone morphogenetic protein-induced bone regeneration in a rat spinal fusion model

• Published in: The spine journal Vol. 24; no. 5; pp. 899 - 908
• Main Authors: Tateiwa, Daisuke, Iwamoto, Masahiro, Kodama, Joe, Ukon, Yuichiro, Hirai, Hiromasa, Ikuta, Masato, Kitahara, Takayuki, Furuichi, Takuya, Bun, Masayuki, Otsuru, Satoru, Okada, Seiji, Kaito, Takashi
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01-05-2024
• Subjects: BMP/Smad signaling; Bone morphogenetic protein; Bone regeneration; Endochondral bone formation; RARγ inverse agonist; Retinoic acid receptor γ; Spinal fusion; BMP/Smad signaling; Retinoic acid receptor γ; Bone morphogenetic protein; Bone regeneration; RARγ inverse agonist; Endochondral bone formation; Spinal fusion
• ISSN: 1529-9430; 1878-1632; 1878-1632
• DOI: 10.1016/j.spinee.2023.11.021

Bone morphogenetic proteins (BMPs) have potent osteoinductivity and have been applied clinically for challenging musculoskeletal conditions. However, the supraphysiological doses of BMPs used in clinical settings cause various side effects that prevent widespread use, and therefore the BMP dosage needs to be reduced.
To address this problem, we synthesized 7C, a retinoic acid receptor γ antagonist-loaded nanoparticle (NP), and investigated its potential application in BMP-based bone regeneration therapy using a rat spinal fusion model.
An experimental animal study.
Fifty-three male 8-week-old Sprague–Dawley rats underwent posterolateral spinal fusion and were divided into the following five treatment groups: (1) no recombinant human (rh)BMP-2 and blank-NP (Control), (2) no rhBMP-2 and 1 μg 7C-NP (7C group), (3) low-dose rhBMP-2 (0.5 μg) and 1 μg blank-NP (L-BMP group), (4) low-dose rhBMP-2 (0.5 μg) and 1 μg 7C-NP (L-BMP + 7C group), and (5) high-dose rhBMP-2 (5.0 μg) and 1 μg blank-NP (H-BMP group). Micro-computed tomography and histologic analysis were performed 2 and 6 weeks after the surgery.
The spinal fusion rates of the Control and 7C groups were both 0%, and those of the L-BMP, L-BMP + 7C, and H-BMP groups were 55.6%, 94.4%, and 100%, respectively. The L-BMP + 7C group markedly promoted cartilaginous tissue formation during BMP-induced endochondral bone formation that resulted in a significantly better spinal fusion rate and bone formation than in the L-BMP group. Although spinal fusion was slower in the L-BMP + 7C group, the L-BMP + 7C group formed a spinal fusion mass with better bone quality than the spinal fusion mass in the H-BMP group.
The combined use of 7C-NP with rhBMP-2 in a rat posterolateral lumbar fusion model increased spinal fusion rate and new bone volume without deteriorating the quality of newly formed bone.
7C-NP potentiates BMP-2-induced bone regeneration and has the potential for efficient bone regeneration with low-dose BMP-2, which can reduce the dose-dependent side effects of BMP-2 in clinical settings.